--2024/Q4-- / 0.000--
Nov 7, 20242024/Q30.000 / 0.000--
Aug 8, 20242024/Q20.000 / 0.000--
May 9, 20242024/Q10.000 / 0.000--
Mar 18, 20242023/Q40.000 / 0.000--
Meta Platforms
META
Coinbase
COIN
Amazon
AMZN
Apple
AAPL
Oracle
ORCL
US Stock MarketDetailed Quotes
LTRN Lantern Pharma
- 3.190
- +0.030+0.95%
Close Dec 3 16:00 ET
- 3.350
- +0.160+5.02%
Post 19:55 ET
34.40MMarket Cap-1792P/E (TTM)
3.380High3.160Low56.19KVolume3.340Open3.160Pre Close185.37KTurnover0.71%Turnover RatioLossP/E (Static)10.78MShares11.99052wk High1.29P/B25.40MFloat Cap2.79052wk Low--Dividend TTM7.96MShs Float24.840Historical High--Div YieldTTM6.96%Amplitude2.380Historical Low3.298Avg Price1Lot Size
Lantern Pharma Key Stats
Lantern Pharma Q3 2024 Earnings Date
Currency：USDNov 7, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 0 | 0 | 0 |
-- | -- | -- | |
| EPS | -0.56 | -0.42 | +0.14 |
| Beat Est. | -93.14% | -44.83% | +24.99% |
Analyst Rating
No Data
Lantern Pharma Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Lantern Pharma Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.